Suscribirse

Impact of dose reduction and iterative reconstruction algorithm on the detectability of pulmonary nodules by artificial intelligence - 30/04/22

Doi : 10.1016/j.diii.2021.12.002 
Moritz Schwyzer a, b, c, d, Michael Messerli c, e, Matthias Eberhard a, c, Stephan Skawran a, c, e, Katharina Martini a, c, , Thomas Frauenfelder a, c
a Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, 8091 Zurich, Switzerland 
b Health Sciences and Technology, Institute of Food, Nutrition and Health, ETH Zurich, 8603 Schwerzenbach, Switzerland 
c University of Zurich, 8006 Zurich, Switzerland 
d School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA 19104, USA 
e Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Highlights

The performance of pulmonary nodule detection by artificial intelligence software is impacted by dose reduction and reconstruction settings.
Chest CT with lower image noise seem to have greater sensitivity and fewer false positive findings compared to reconstruction settings with high image noise when using fully automatic nodule detection software.
When using fully automatic nodule detection software at reduced radiation dose levels, increasing strength levels of iterative reconstruction might improve sensitivity and reduce false positive findings.

El texto completo de este artículo está disponible en PDF.

Abstract

Purpose

The purpose of this study was to assess whether the performances of an automated software for lung nodule detection with computed tomography (CT) are affected by radiation dose and the use of iterative reconstruction algorithm.

Materials and methods

A chest phantom (Multipurpose Chest Phantom N1; Kyoto Kagaku Co. Ltd, Kyoto, Japan) with 15 pulmonary nodules was scanned with a total of five CT protocol settings with up to 20-fold dose reduction. All CT examinations were reconstructed with iterative reconstruction algorithms ADMIRE 3 and ADMIRE 5 and were then analyzed for the presence of pulmonary nodules with a fully automated computer aided detection software system (InferReadTM CT Lung, Infervision), which is based on deep neural networks.

Results

The sensitivity of fully automated pulmonary nodule detection for ground-glass nodules at standard dose CT was greater (70.0%; 14/20; 95% CI: 51.6-88.4%) than at 10-fold and 20-fold dose reduction (30.0%; 6/20; 95% CI: 0.0%-62.5%). There were less false positive findings when ADMIRE 5 reconstruction was used (4.0 ± 2.8 [SD]; range: 2–6) instead of ADMIRE 3 reconstruction (25.0 ± 15.6 [SD]; range: 14–36). There was no difference in the sensitivity of detection of solid and subsolid nodules between standard dose (100%; 95% CI: 100–100%) and 10- and 20-fold reduced dose CT (92.5%; 95% CI: 83.8–100.0%). Image noise was significantly greater with ADMIRE 3 (81 ± 2 [SD] [range: 79–84]; 104 ± 3 [SD] [range: 101–107]; 114 ± 5 [SD] [range: 110–119]; 193 ± 10 [SD] [range: 183-203]; 220 ± 16 [SD] [range: 210–238]) compared to ADMIRE 5 (44 ± 2 [SD] [range: 42–46]; 60 ± 2 [SD] [range: 57–61]; 66 ± 1 [SD] [range: 65–67]; 103 ± 4 [SD] [range: 98–106]; 110 ± 1 [SD] [range: 109–111]), respectively in each of the five CT protocols.

Conclusion

This phantom study suggests that dose reduction and iterative reconstruction settings have an impact on detectability of pulmonary nodules by artificial intelligence software and we therefore encourage adaption of dose levels and reconstruction methods prior to widespread implementation of fully automatic nodule detection software for lung cancer screening purposes.

El texto completo de este artículo está disponible en PDF.

Keywords : Artificial intelligence, Dose reduction, Iterative reconstruction algorithm, Lung nodule, Nodule detection

Abbreviations : ADMIRE, CI, CNR, CT, DLP, HU, kV, mAs, mSv, PACS, ROI


Esquema


© 2021  The Author(s). Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 103 - N° 5

P. 273-280 - mai 2022 Regresar al número
Artículo precedente Artículo precedente
  • Accuracy of a CT density threshold enhancement to identify pancreatic parenchyma necrosis in acute pancreatitis during the first week
  • Jean Pierre Tasu, Raphael Le Guen, Inès Ben Rhouma, Ayoub Guerrab, Nadeem Beydoun, Brice Bergougnoux, Pierre Ingrand, Guillaume Herpe
| Artículo siguiente Artículo siguiente
  • Unexpected discovery of ballistic metallic foreign bodies on postmortem imaging examinations
  • Sylvain Grange, Carolyne Bidat-Callet, Rémi Grange, Fabrice-Guy Barral, Michel Peoc'h, Thema Mokrane, Fabrice Dedouit

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.